文献速递产科母胎医学

胎盘植入谱系疾病保守治疗后的后续妊娠分娩结局:系统综述与荟萃分析

Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2023-11-02

该系统综述与荟萃分析检索截至2022年9月,纳入5项研究共1458名参与者,评估胎盘植入谱系疾病保守治疗后首次后续妊娠的结局。后续妊娠中胎盘植入谱系疾病复发率为11.8%(95%CI 1.1-60.3;I²=86.4%),约1/4后续妊娠出现显著不良母体结局。作者认为在管理该人群时,患者和提供者的准备至关重要。

要点

  • 后续妊娠胎盘植入谱系疾病复发率为11.8%(95%CI 1.1-60.3;I²=86.4%)。
  • 后续妊娠中1.9%的参与者接受剖宫产子宫切除术(95%CI 0.0-34.1;I²=82.4%)。
  • 复合不良母体结局发生于22.7%的参与者(95%CI 0.0-99.4;I²=56.3%)。

核心结论

  • 胎盘植入谱系疾病妊娠成功保留子宫后,后续妊娠仍可能获得良好结局,但约1/4的后续妊娠出现显著不良母体结局,鉴于不良结局和发病率高,管理该人群时患者和提供者的准备至关重要。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Scopus和Web of Science数据库从建库至2022年9月,纳入报告胎盘植入谱系疾病保守治疗后首次后续妊娠结局的所有研究(病例研究除外)。
  • 共纳入5项研究涉及1458名参与者进行定量合成。
  • 保守治疗类型包括胎盘原位保留(n=1)和切除手术(n=1),3项研究未报告保守治疗类型。

主要发现

  • 后续妊娠胎盘植入谱系疾病复发率为11.8%(95%CI 1.1-60.3;I²=86.4%)。
  • 1.9%的参与者接受剖宫产子宫切除术(95%CI 0.0-34.1;I²=82.4%)。
  • 产后出血发生于10.3%的参与者(95%CI 0.3-81.4;I²=96.7%)。
  • 复合不良母体结局报告于22.7%的参与者(95%CI 0.0-99.4;I²=56.3%)。

临床怎么用

  • 作者认为,鉴于后续妊娠不良结局和发病率高,管理胎盘植入谱系疾病保守治疗后计划妊娠的人群时,患者和提供者的准备至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cesarean hysterectomy is generally presumed to decrease maternal morbidity and mortality secondary to placenta accreta spectrum disorder. Recently, uterine-sparing techniques have been introduced in conservative management of placenta accreta spectrum disorder to preserve fertility and potentially reduce surgical complications. However, despite patients often expressing the intention for future conception, few data are available regarding the subsequent pregnancy outcomes after conservative management of placenta accreta spectrum disorder. Thus, we aimed to perform a systematic review and meta-analysis to assess these outcomes. DATA SOURCES: PubMed, Scopus, and Web of Science databases were searched from inception to September 2022. STUDY ELIGIBILITY CRITERIA: We included all studies, with the exception of case studies, that reported the first subsequent pregnancy outcomes in individuals with a history of placenta accreta spectrum disorder who underwent any type of conservative management. METHODS: The R programming language with the "meta" package was used. The random-effects model and inverse variance method were used to pool the proportion of pregnancy outcomes. RESULTS: We identified 5 studies involving 1458 participants that were eligible for quantitative synthesis. The type of conservative management included placenta left in situ (n=1) and resection surgery (n=1), and was not reported in 3 studies. The rate of placenta accreta spectrum disorder recurrence in the subsequent pregnancy was 11.8% (95% confidence interval, 1.1-60.3; I2=86.4%), and 1.9% (95% confidence interval, 0.0-34.1; I2=82.4%) of participants underwent cesarean hysterectomy. Postpartum hemorrhage occurred in 10.3% (95% confidence interval, 0.3-81.4; I2=96.7%). A composite adverse maternal outcome was reported in 22.7% of participants (95% confidence interval, 0.0-99.4; I2=56.3%). CONCLUSION: Favorable pregnancy outcome is possible following successful conservation of the uterus in a placenta accreta spectrum disorder pregnancy. Approximately 1 out of 4 subsequent pregnancies following conservative management of placenta accreta spectrum disorder had considerable adverse maternal outcomes. Given such high incidence of adverse outcomes and morbidity, patient and provider preparation is vital when managing this population.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Javinani A, Qaderi S, Hessami K, et al. Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023. PMID: 37918506. doi:10.1016/j.ajog.2023.10.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。